A Nurse Practitioner-Driven Palliative Care Intervention Improves Cancer Patients' Quality of Life, Mayo Clinic Study Says
Recent studies have shown that palliative care interventions aimed at addressing patients' emotional, spiritual and social needs have a significant impact on cancer patients' quality of life and may even improve cancer patients' overall survival. View More (2012-05-21)
Testing for mutations identified in squamous cell lung cancer tumors helps personalize treatment
Screening lung cancer tumor samples for cancer-causing, or "driver," genetic mutations can help physicians tailor patients' treatments to target those specific mutations. View More (2012-05-18)
Revised glioblastoma classification should improve patient care
Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors. View More (2012-05-17)
Children with cancer have complete responses in a Children's Oncology Group phase 1 trial
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma. View More (2012-05-17)
Chemotherapy's effect on overall survival seems to increase based on tumor size
The most recent research released in June's Journal of Thoracic Oncology indicates there might be a positive correlation between tumor size and adjuvant platinum based chemotherapy in surgically resected patients with node negative non-small cell lung cancer. View More (2012-05-16)
A marker in the lining of the lungs could be useful diagnostic technique for lung cancer screening
The most recent research released in June's Journal of Thoracic Oncology says molecular biomarkers in the tissue and fluid lining the lungs might be an additional predictive technique for lung cancer screening. View More (2012-05-16)
Video-assisted thoracic surgery valuable tool in lung cancer screening
The most recent research released in June's Journal of Thoracic Oncology says video assisted thoracic surgery (VATS) is a valuable tool in managing lesions detected in a lung cancer screening program. View More (2012-05-16)
UCI study finds racial, economic disparities in ovarian cancer care, survival
Poor women and African Americans with ovarian cancer are less likely to receive the highest standards of care, leading to worse outcomes than among white and affluent patients. View More (2012-05-09)
Protein may represent a switch to turn off B cell lymphoma
Researchers studying the molecular signals that drive a specific type of lymphoma have discovered a key biological pathway leading to this type of cancer. View More (2012-05-08)
UT MD Anderson study finds cancer related pain often undertreated
More than one third of patients with invasive cancer are undertreated for their pain, with minorities twice as likely to not receive analgesics, according to research from The University of Texas MD Anderson Cancer Center. View More (2012-04-17)
Michigan cancer programs follow care guidelines for common cancers, study finds
A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study. View More (2012-04-11)
Drug combination may provide option to patients with NSCLC ineligible for bevacizumab
A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab. View More (2012-04-03)
Oxygen in tumors predicts prostate cancer recurrence
Low oxygen levels in tumors can be used to predict cancer recurrence in men with intermediate-risk prostate cancer even before they receive radiation therapy. View More (2012-04-02)
The protein survivin could be a useful biomarker for pancreatic cancer
Pancreatic cancer kills more than 40,000 people every year, and among cancers it's particularly insidious. For 80 percent of patients, the disease is already so advanced at the time of diagnosis that treatment is unlikely to provide significantly life-extending benefits. View More (2012-04-02)
IMRT reduces risk of side effects in breast cancer patients
Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities. View More (2012-03-29)
Panel of serum biomarkers may reduce number of lung biopsies needed
A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis. View More (2012-03-16)
Pleurectomy/decortication proposed preferred surgical procedure
Patients with early stage malignant pleural mesothelioma (MPM), a cancer that develops in the lining of the lungs, may be eligible for aggressive multi-modality therapy involving surgery, radiotherapy and chemotherapy. View More (2012-03-16)
CYFRA21-1 might be predictive marker in advanced NSCLC
Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. View More (2012-03-16)
The loss of a protein makes 'jump' the tumor to the lymph node
Metastasis is responsible for 90% of deaths in patients with cancer. Understanding the mechanisms responsible for this process is one of the top goals of cancer research. View More (2012-03-07)
Moffitt Cancer Center Researchers Find Sarcoma Tumor Immune Response With Combination Therapy
A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells) and fractionated external beam radiation (EBRT) provided more than 50 percent of their trial patients with tumor-specific immune responses lasting from 11 to 42 weeks. View More (2012-03-02)
|
|
